Skip to main content
Elsevier

Journals in Pharmaceutical sciences

Elsevier's Pharmaceutical Sciences collection helps pharmaceutical scientists striving to optimize drug design and improve healthcare outcomes by offering comprehensive coverage of every aspect of drug development, integrating disciplines like organic chemistry, biology, and biotechnology. Focused on safety, efficacy, and formulation design, it includes specialized fields such as Clinical Pharmacology and Translational Research, providing valuable insights into the latest advancements in drug discovery.

  • Journal of Clinical Epidemiology

    • ISSN: 0895-4356
    Metascience and innovative methods to improve population healthThe Journal of Clinical Epidemiology (JCE) aims to advance science that can improve health care decision-making and contribute to the evolving discipline of clinical epidemiology. The JCE publishes methods-focused articles across the spectrum of the research ecosystem, including primary research (qualitative, quantitative, and mixed); evidence syntheses; guidelines; and implementation science. The journal welcomes registered reports, protocols, and simulation studies that advance the journal’s aims. The JCE promotes inclusive research and health equity and is committed to ensuring a diversity of perspectives across its content, contributors, editorial board, and leadership.The journal publishes topics including:Meta-scien... researchDevelopment, evaluation, and implementation of reporting guidelines Research integrity and cultureOpen scienceEmerging methodologies Developing and evaluating outcome measuresEducation and learning programs for clinical epidemiologistThe JCE does not accept the following submissions except in exceptional circumstances: Bibliometric studies and those on infodemiology, social media trends, and health informaticsPapers written primarily for a statistical audience Artificial intelligence and machine learning studies without critical evaluation of the method and transparent reportingMeta-resear... studies that demonstrate weaknesses or limitations in the evidence ecosystem but lack reflection on how these might be addressedEffectivene... studies, including Mendelian randomization studies and target trial emulations; systematic reviews; prevalence and incidence studies; prognostic or diagnostic research where the main focus is not on the methodsStudies limited to one country, jurisdiction, or clinical area with limited generalizability, such as: translating an outcome measure into a different language; a study focused on one clinical specialty; a Delphi/consensus-bas... study where all the authors are from one country; or a survey of participants from one setting or with a limited response rateStudies with a single author where it was more appropriate for a multi-disciplinary team to conduct the researchStudies that do not include patient partners as members of the research team in circumstances where that would be considered essentialAnimal studies Pharmacovigilance and pharmacoepidemiology studies
    Subscriptions

  • Advanced Drug Delivery Reviews

    • ISSN: 0169-409X
    The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery.In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues.Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution.Theme issues are commissioned by one of the Executive Editors or the Editor-in-Chief. The Journal does not publish stand alone manuscripts. If you wish to submit a theme issue topic for consideration, please contact one of the editors.
    Subscriptions

  • Journal of Controlled Release

    • ISSN: 0168-3659
    The Journal of Controlled Release (JCR) is the Official Journal of the Controlled Release Society, and of the Japan Society of Drug Delivery System.It publishes high-quality research articles in the broad field of delivery science and technology. This includes drug delivery systems and all aspects of formulations, such as physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development in the disciplines of pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries.Manuscrip... that advance fundamental understanding of principles and/or demonstrate advantages of novel technologies in safety and efficacy over current clinical standards will be given priority.
    Subscriptions

  • Drug Resistance Updates

    • ISSN: 1368-7646
    Drug Resistance Updates publishes inspiring original research, commentary and expert reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance. It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology, and clinical medicine. The Editors welcome and encourage the submission of original research articles while review articles are written by leaders in the field of drug resistance by invitation.
    Subscriptions

Related subjects